“Delaying the Onset of Type 1 Diabetes With Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated”. 2022. Journal of Clinical Diabetes and Obesity 2 (1): 7-12. https://doi.org/10.5281/zenodo.22238844.